Imunon Statistics

Total Valuation

Imunon has a market cap or net worth of $31.02 million. The enterprise value is $30.03 million.

Market Cap	31.02M
Enterprise Value	30.03M

Important Dates

The last earnings date was Monday, May 12, 2025, before market open.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Imunon has 21.84 million shares outstanding. The number of shares has increased by 37.24% in one year.

Current Share Class	21.84M
Shares Outstanding	21.84M
Shares Change (YoY)	+37.24%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	1.02%
Owned by Institutions (%)	5.06%
Float	19.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	54.99
P/TBV Ratio	70.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.88, with a Debt / Equity ratio of 2.23.

Current Ratio	0.88
Quick Ratio	0.50
Debt / Equity	2.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -397.54% and return on invested capital (ROIC) is -199.09%.

Return on Equity (ROE)	-397.54%
Return on Assets (ROA)	-107.77%
Return on Invested Capital (ROIC)	-199.09%
Return on Capital Employed (ROCE)	-1,714.83%
Revenue Per Employee	n/a
Profits Per Employee	-$711,728
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.26% in the last 52 weeks. The beta is 2.14, so Imunon's price volatility has been higher than the market average.

Beta (5Y)	2.14
52-Week Price Change	+5.26%
50-Day Moving Average	1.02
200-Day Moving Average	0.96
Relative Strength Index (RSI)	51.87
Average Volume (20 Days)	31,351,134

Short Selling Information

The latest short interest is 1.15 million, so 5.25% of the outstanding shares have been sold short.

Short Interest	1.15M
Short Previous Month	1.02M
Short % of Shares Out	5.25%
Short % of Float	5.95%
Short Ratio (days to cover)	4.83

Income Statement

Revenue	n/a
Gross Profit	1.13M
Operating Income	-18.27M
Pretax Income	-20.13M
Net Income	-17.79M
EBITDA	-18.03M
EBIT	-18.27M
Earnings Per Share (EPS)	-$1.39

Full Income Statement

Balance Sheet

The company has $2.87 million in cash and $1.01 million in debt, giving a net cash position of $1.86 million or $0.09 per share.

Cash & Cash Equivalents	2.87M
Total Debt	1.01M
Net Cash	1.86M
Net Cash Per Share	$0.09
Equity (Book Value)	452,028
Book Value Per Share	0.03
Working Capital	-704,931

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$15.83 million and capital expenditures -$277,438, giving a free cash flow of -$16.11 million.

Operating Cash Flow	-15.83M
Capital Expenditures	-277,438
Free Cash Flow	-16.11M
FCF Per Share	-$0.74

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Imunon does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.24%
Shareholder Yield	-37.24%
Earnings Yield	-55.79%
FCF Yield	-50.50%

Analyst Forecast

The average price target for Imunon is $14.00, which is 885.92% higher than the current price. The consensus rating is "Buy".

Price Target	$14.00
Price Target Difference	885.92%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 1, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Mar 1, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1